NIVF Stock Analysis: Buy, Sell, or Hold?
NIVF - NewGenIvf Group Limited Class A ordinary shares
$1.02
-0.10 (-8.93%)
▼
5d:
+13.33%
30d:
-46.6%
90d:
+27.52%
HOLD
MODERATE Confidence
Analysis Updated: May 22, 2026 12:00 AM ET
Earnings: Jun 30, 2026
Get Alerted When NIVF Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called NIVF this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NIVF shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NIVF shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.64
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$2.26
54.8% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 0.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NIVF is currently trading at $1.02, which is considered oversold relative to its 30-day fair value range of $1.07 to $2.11. From a valuation perspective, the stock is trading at a discount (Forward PE: 0.1) compared to its historical average (0.2). Remarkably, the market is currently pricing in an annual earnings decline of 13.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NIVF is in a uptrend. Immediate support is located at $0.73, while resistance sits at $1.60. Short-term momentum is weak, with the stock down 8.9% recently.
Market Sentiment: NIVF has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $900.00 (+88135.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NIVF is in a uptrend. Immediate support is located at $0.73, while resistance sits at $1.60. Short-term momentum is weak, with the stock down 8.9% recently.
Market Sentiment: NIVF has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $900.00 (+88135.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.07 -
$2.11
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-8.9%)
- BULLISH: Trading 88135.3% below Wall St target ($900.00)
Trading Range Analysis
30-Day Trading Range
$1.07 -
$2.11
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.73
Resistance Level
$1.60
Current Trend
Uptrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
0.11
Wall Street Target
$900.00
(+88135.3%)
Revenue Growth (YoY)
11.9%
Profit Margin
209.0%
Valuation Discount vs History
-13.5% cheaper
PE vs Historical
0.1 vs 0.2
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-13.5%
(market-implied from PE analysis)
1-Year Target
$0.92
(-10%)
2-Year Target
$0.83
(-19%)
3-Year Target
$0.74
(-27%)
3-Yr Target (if PE normalizes)
(PE: 0→0)
$1.36
(+34%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 97.0%)
$693.18
(+67859%)
Base:
(SPY PE: 0.1, Growth: 97.0%)
$3.44
(+238%)
Bear:
(PE: 0.1, Growth: 97.0%)
$2.93
(+187%)
📈
Valuation based on Current Earnings
Trailing PE: 0.03 | Current EPS (TTM): $36.48
Bull Case
$0.62
(-40%)
Analyst growth -50.0%, PE expands to 0.0
Base Case
$0.56
(-45%)
Market implied -50.0%, PE stable at 0.0
Bear Case
$0.76
(-25%)
Severe decline -20.0%, PE contracts to 0.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 0.1 to 0.2
Stabilization Target:
$1.87
(+83.1%)
PE Expansion Potential:
+83.1%
Share & Embed Analysis
Last updated: May 22, 2026 10:35 PM ET
Data refreshes hourly during market hours. Next update: 11:35 PM
Data refreshes hourly during market hours. Next update: 11:35 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NIVF showing a specific setup today?
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 59 HOLD |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 51 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$23 | 63 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 52 HOLD |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$31 | 60 HOLD |
